top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Intracellular Delivery III : Market Entry Barriers of Nanomedicines / / edited by Aleš Prokop, Volkmar Weissig
Intracellular Delivery III : Market Entry Barriers of Nanomedicines / / edited by Aleš Prokop, Volkmar Weissig
Edizione [1st ed. 2016.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016
Descrizione fisica 1 online resource (XIII, 453 p. 81 illus., 65 illus. in color.)
Disciplina 615.6
Collana Fundamental Biomedical Technologies
Soggetto topico Medicine
Nanotechnology
Biomedicine, general
ISBN 3-319-43525-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto 1 Overview of present problems facing commercialization of nanomedicines, Aleš Prokop and Volkmar Weissig -- 2 Precision medicine and site-specific drug delivery, Karel Petrák -- 3 Extracellular matrix degrading enzymes for nanocarrier-based anticancer therapy, Pablo Scodeller -- 4 Nanocarrier-based anticancer therapies with the focus on strategies for targeting the tumor microenvironment, Francisca Leonard and Biana Godin -- 5 New approach to minimize the MPS/RES uptake resulting a reduce toxic side effects of nanodrugs, Li Liu and Chien Ho -- 6 Authentic vascular and stromal structure in animal disease model for nanomedicine, Hiroshi Nishihara and Mitsunobu R Kano -- 7 Ligand-targeted nanocarriers with respect to their translation into the clinic, in particular in comparison with non-targeted nano-medicines, Roy Van der Meel, Laurens J.C. Vehmeijer, Robbert Jan Kok, Gert Storm, Ethlinn V.B. van Gaaland Gert Storm -- 8 Anti-angiogenic therapy by targeting the tumor vasculature with liposomes, Yu Sakurai and Hideyoshi Harashima -- 9 Accessing mitochondrial targets using nanocargos, Ru Wen, Afoma C. Umeano and Shanta Dhar -- 10 Redox-responsive nano-delivery systems for cancer therapy, Amit Singh, Thanh-Huyen Tran and Mansoor M. Amiji -- 11 Nano-emulsions for drug delivery and biomedical imaging, Nicolas Anton, François Hallouard, Mohammed F. Attia and Thierry F. Vandamme -- 12 The tumor microenvironment in nanoparticle delivery and the role of Imaging to navigate roadblocks and pathways, Dmitri Artemov and Zaver M Bhujwalla -- 13 Microscopic mass spectrometry for the precise design of drug delivery systems, Yasuhiro Matsumura and Masahiro Yasunaga -- 14 Pharmacokinetics and pharmacodynamics of nano-drug delivery systems, David Stepensky -- 15 Intracellular drug delivery in PBPK modelling though active and passive transport processes, Lars Kuepfer, Christoph Niederalt, Thomas Wendl, Jan-Frederil Schlender, Michael Block, Thomas Eissing, Donato Teutonic -- 16 Exploiting nanocarriers for combination cancer therapy, Yi Wen Kong, Erik C. Dreaden, Paula T. Hammond and Michael B. Yaffe -- 17 Commercialization of nanotechnology for medical applications, David W. Hobson -- Index.
Record Nr. UNINA-9910148843103321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Organelle-specific pharmaceutical nanotechnology [[electronic resource] /] / edited by Volkmar Weissig, Gerard G.M. D'Souza
Organelle-specific pharmaceutical nanotechnology [[electronic resource] /] / edited by Volkmar Weissig, Gerard G.M. D'Souza
Pubbl/distr/stampa Hoboken, NJ, : Wiley, 2010
Descrizione fisica 1 online resource (638 p.)
Disciplina 615/.19
Altri autori (Persone) WeissigVolkmar
D'SouzaGerard G. M
Soggetto topico Pharmaceutical technology
Nanotechnology
Drug targeting
ISBN 1-118-07434-3
1-299-18614-9
0-470-87578-X
0-470-87577-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ORGANELLE-SPECIFIC PHARMACEUTICAL NANOTECHNOLOGY; CONTENTS; PREFACE; CONTRIBUTORS; CHAPTER 1: An Introduction to Subcellular Nanomedicine: Current Trends and Future Developments; CHAPTER 2: Delivery of Nanosensors to Measure the Intracellular Environment; CHAPTER 3: Cytoplasmic Diffusion of Dendrimers and Dendriplexes; CHAPTER 4: Endocytosis and Intracellular Trafficking of Quantum Dot-Ligand Bioconjugates; CHAPTER 5: Synthesis of Metal Nanoparticle-Based Intracellular Biosensors and Therapeutic Agents; CHAPTER 6: Subcellular Fate of Nanodelivery Systems
CHAPTER 7: Intracellular Fate of Plasmid DNA PolyplexesCHAPTER 8: Intracellular Traffi cking of Membrane Receptor-Mediated Uptake of Carbon Nanotubes; CHAPTER 9: Real-Time Particle Tracking for Studying Intracellular Transport of Nanotherapeutics; CHAPTER 10: Tracking Intracellular Polymer Localization Via Fluorescence Microscopy; CHAPTER 11: Can QSAR Models Describing Small-Molecule Xenobiotics Give Useful Tips for Predicting Uptake and Localization of Nanoparticles in Living Cells? And If Not, Why Not?; CHAPTER 12: Self-Unpacking Gene Delivery Scaffolds
CHAPTER 13: Cellular Trafficking of DendrimersCHAPTER 14: Endolysosomolytically Active pH-Sensitive Polymeric Nanotechnology; CHAPTER 15: Uptake and Intracellular Dynamics of Proteins Internalized by Cell-Penetrating Peptides; CHAPTER 16: Cargo Transport by Teams of Molecular Motors: Basic Mechanisms for Intracellular Drug Delivery; CHAPTER 17: The Potential of Photochemical Internalization (PCI) for the Cytosolic Delivery of Nanomedicines; CHAPTER 18: Peptide-Based Nanocarriers for Intracellular Delivery of Biologically Active Proteins
CHAPTER 19: Organelle-Specific Pharmaceutical Nanotechnology: Active Cellular Transport of Submicro- and Nanoscale ParticlesCHAPTER 20: Subcellular Targeting of Virus-Envelope-Coated Nanoparticles; CHAPTER 21: Mitochondria-Targeted Pharmaceutical Nanocarriers; CHAPTER 22: Cell-Penetrating Peptides for Cytosolic Delivery of Biomacromolecules; CHAPTER 23: Therapeutic Nano-object Delivery to Subdomains of Cardiac Myocytes; CHAPTER 24: Design Parameters Modulating Intracellular Drug Delivery: Anchoring to Specific Cellular Epitopes, CarrierGeometry, and Use of Auxiliary Pharmacological Agents
CHAPTER 25: Uptake Pathways Dependent Intracellular Trafficking of DNA Carrying Nanodelivery SystemsCHAPTER 26: Cellular Interactions of Plasmon-Resonant Gold Nanorods; CHAPTER 27: Quantum Dot Labeling for Assessment of Intracellular Trafficking of Therapeutically Active Molecules; INDEX
Record Nr. UNINA-9910140835903321
Hoboken, NJ, : Wiley, 2010
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Organelle-specific pharmaceutical nanotechnology / / edited by Volkmar Weissig, Gerard G.M. D'Souza
Organelle-specific pharmaceutical nanotechnology / / edited by Volkmar Weissig, Gerard G.M. D'Souza
Edizione [1st ed.]
Pubbl/distr/stampa Hoboken, NJ, : Wiley, 2010
Descrizione fisica 1 online resource (638 p.)
Disciplina 615/.19
Altri autori (Persone) WeissigVolkmar
D'SouzaGerard G. M
Soggetto topico Pharmaceutical technology
Nanotechnology
Drug targeting
ISBN 1-118-07434-3
1-299-18614-9
0-470-87578-X
0-470-87577-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto ORGANELLE-SPECIFIC PHARMACEUTICAL NANOTECHNOLOGY; CONTENTS; PREFACE; CONTRIBUTORS; CHAPTER 1: An Introduction to Subcellular Nanomedicine: Current Trends and Future Developments; CHAPTER 2: Delivery of Nanosensors to Measure the Intracellular Environment; CHAPTER 3: Cytoplasmic Diffusion of Dendrimers and Dendriplexes; CHAPTER 4: Endocytosis and Intracellular Trafficking of Quantum Dot-Ligand Bioconjugates; CHAPTER 5: Synthesis of Metal Nanoparticle-Based Intracellular Biosensors and Therapeutic Agents; CHAPTER 6: Subcellular Fate of Nanodelivery Systems
CHAPTER 7: Intracellular Fate of Plasmid DNA PolyplexesCHAPTER 8: Intracellular Traffi cking of Membrane Receptor-Mediated Uptake of Carbon Nanotubes; CHAPTER 9: Real-Time Particle Tracking for Studying Intracellular Transport of Nanotherapeutics; CHAPTER 10: Tracking Intracellular Polymer Localization Via Fluorescence Microscopy; CHAPTER 11: Can QSAR Models Describing Small-Molecule Xenobiotics Give Useful Tips for Predicting Uptake and Localization of Nanoparticles in Living Cells? And If Not, Why Not?; CHAPTER 12: Self-Unpacking Gene Delivery Scaffolds
CHAPTER 13: Cellular Trafficking of DendrimersCHAPTER 14: Endolysosomolytically Active pH-Sensitive Polymeric Nanotechnology; CHAPTER 15: Uptake and Intracellular Dynamics of Proteins Internalized by Cell-Penetrating Peptides; CHAPTER 16: Cargo Transport by Teams of Molecular Motors: Basic Mechanisms for Intracellular Drug Delivery; CHAPTER 17: The Potential of Photochemical Internalization (PCI) for the Cytosolic Delivery of Nanomedicines; CHAPTER 18: Peptide-Based Nanocarriers for Intracellular Delivery of Biologically Active Proteins
CHAPTER 19: Organelle-Specific Pharmaceutical Nanotechnology: Active Cellular Transport of Submicro- and Nanoscale ParticlesCHAPTER 20: Subcellular Targeting of Virus-Envelope-Coated Nanoparticles; CHAPTER 21: Mitochondria-Targeted Pharmaceutical Nanocarriers; CHAPTER 22: Cell-Penetrating Peptides for Cytosolic Delivery of Biomacromolecules; CHAPTER 23: Therapeutic Nano-object Delivery to Subdomains of Cardiac Myocytes; CHAPTER 24: Design Parameters Modulating Intracellular Drug Delivery: Anchoring to Specific Cellular Epitopes, CarrierGeometry, and Use of Auxiliary Pharmacological Agents
CHAPTER 25: Uptake Pathways Dependent Intracellular Trafficking of DNA Carrying Nanodelivery SystemsCHAPTER 26: Cellular Interactions of Plasmon-Resonant Gold Nanorods; CHAPTER 27: Quantum Dot Labeling for Assessment of Intracellular Trafficking of Therapeutically Active Molecules; INDEX
Record Nr. UNINA-9910821147803321
Hoboken, NJ, : Wiley, 2010
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui